HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

Researchers in Italy observed a significant reduction in antibiotic use for sexually transmitted infections after the targeted introduction of doxyPEP.

It was supposed to be a banner year in the fight against the HIV epidemic. Nationwide infection rates were gradually falling, ...

In this week’s edition of The Prototype, we look at a quantum computing milestone for biotech, a new way to get forever ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...